Contact information
Research groups
Xinchun Gu
PhD
Researcher
I am an epidemiologist and pharmacist, with my research primarily focusing on the surveillance of infectious diseases in England and the evaluation of vaccine uptake, efficacy and safety. I currently use primary care data from the Oxford-Royal College of General Practitioners Research and Surveillance Centre (Oxford-RCGP RSC), which collects data from more than 1900 practices across England and Wales, to evaluate the trend of respiratory infectious disease in the UK. I am also experienced in using primary care data from Clinical Practice Research Datalink (CPRD) and its linked external databases.
I currently supervise postgraduate students in the MSc in Applied Digital Health. I am a tutor for the Meta-Analysis module and the Big Data Epidemiology module in MSc degree programs.
Prior to joining the University of Oxford, I completed my PhD in pharmacoepidemiology at the University of Manchester, focusing on the safety of gabapentinoids in patients with chronic non-cancer pain in primary care. I earned a Master's degree in Clinical Pharmacy from Peking University, specialising in endocrinology, and a Bachelor's degree in Pharmaceutical Science from Sun Yat-Sen University.
Recent publications
-
Targeted Interventions to Improve the Systematic Collection of Acute Respiratory Infection Clinical Data from Primary Care Computerised Medical Records
Journal article
Jamie G. et al, (2025), Studies in Health Technology and Informatics, 327, 278 - 282
-
Clinical Characteristics of Virologically Confirmed Respiratory Syncytial Virus in English Primary Care: Protocol for an Observational Study of Acute Respiratory Infection
Journal article
Hoang U. et al, (2025), JMIR Research Protocols, 14
-
COVID-19 and influenza vaccine uptake among pregnant women in national cohorts of England and Wales
Journal article
Gu X. et al, (2024), npj Vaccines, 9
-
A protocol to differentiate the COVID-19 infection and vaccine experiences of patients with systemic, single site and overlap immune-mediated inflammatory disease (IMID) (Preprint)
Preprint
Leston M. et al, (2024)
-
Sleeper frameworks for Pathogen X: surveillance, risk stratification, and the effectiveness and safety of therapeutic interventions
Journal article
de Lusignan S. et al, (2024), The Lancet Infectious Diseases, 24, e417 - e418